MedTrace Logo

Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients

NCT00466882 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-11-30

No results posted yet for this study

Summary

The purpose of this study is to assess the use of this Lap-Band system for the purpose of promoting weight loss in renal failure patients who do not qualify as transplant candidates because of excessive BMI's

Conditions

Interventions

DEVICE

Inamed Lap-Band System

Patient's will be seen in the physician's office one week post surgery and once a month thereafter. The device can be gradually adjusted by the insertion of a needle into the port and saline is added or removed to inflate or deflate the LAPBAND. This can be conducted in the physician's office setting to enable the patient to lose 1-2 pounds per week over two years.

Sponsors & Collaborators

  • Summa Health System

    lead OTHER

Principal Investigators

  • John Zografakis, MD · Summa Health System

  • Tanamay Lal, MD · Summa Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-17
Primary Completion
2010-11-30
Completion
2011-01-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00466882 on ClinicalTrials.gov